PTI will launch the VeriPac LPX Series of fully automated package quality inspection systems for 100% inline testing at Interphex, October 19-21, 2021 at the Jacob Javits Convention Center in New York City in Booth 3119. The VeriPac LPX features a dynamic robotic design, tailored to fit your production requirements.
The LPX Series are scalable, modular solutions to meet production line demands. This adaptable platform provides reliable automated handling of a variety of packaging formats. Applications for LPX automation range from flexible package integrity testing to rigid containers and container closure integrity testing of parenteral products.
“VeriPac LPX enables enhanced automated testing that provides a high level of confidence in packaging line performance, stated Scott Audette”, VP Sales & Marketing. “The LPX is a practical and reliable solution to the problems associated with performing infrequent testing, allowing for process-related quality issues to be recognized and corrected sooner rather than later. VeriPac vacuum decay technology has been proven to be the most sensitive, most reliable vacuum-based leak test method on the market, backed by decades of dependable performance in the pharmaceutical, biologics and medical device industries.” Sensitivity and reliability go hand in hand with CCI testing. The VeriPac LPX 430.8S is the next generation automated inspection system for CCI of Parenteral products. Automated for 100% testing or batch release, the VeriPac 430.8S is an eight-station dual chamber design robotic test platform for pre-filled syringes and vials, testing products filled with lyophilized product, small molecule liquids and Water for Injection (WFI).
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox! Sign up now!